Stop taking INVOKANA ® and call your doctor right away if you get any of the following symptoms: nausea, vomiting, stomach-area pain, tiredness, or trouble breathing. Ketoacidosis can happen with INVOKANA ® even if your blood sugar is less than 250 mg/dL. Ketoacidosis is a serious condition, which may need to be treated in a hospital. Ketoacidosis has also happened in people with diabetes who were sick or who had surgery during treatment with INVOKANA ®. Ketoacidosis has happened in people who have type 1 or type 2 diabetes, during treatment with INVOKANA ®. Ketoacidosis (increased ketones in your blood or urine).Call your healthcare provider right away if you reduce the amount of food or liquid you drink, for example if you cannot eat or you start to lose liquids from your body, for example from vomiting, diarrhea, or being in the sun too long. Talk to your doctor about what you can do to prevent dehydration including how much fluid you should drink on a daily basis. You may be at higher risk of dehydration if you take medicines to lower your blood pressure (including diuretics ), are on a low sodium (salt) diet, have kidney problems, or are 65 years of age or older. There have been reports of sudden worsening of kidney function in people with type 2 diabetes who are taking INVOKANA ®. INVOKANA ® can cause some people to become dehydrated (the loss of too much body water), which may cause you to feel dizzy, faint, lightheaded, or weak, especially when you stand up (orthostatic hypotension). Talk to your doctor about proper foot care. Your doctor may decide to stop your INVOKANA ® for a while if you have any of these signs or symptoms. Call your doctor right away if you have new pain or tenderness, any sores, ulcers, or infections in your leg or foot. You may be at a higher risk of lower-limb amputation if you: have a history of amputation, have heart disease or are at risk for heart disease, have had blocked or narrowed blood vessels (usually in leg), have damage to the nerves (neuropathy) in the leg, or have had diabetic foot ulcers or sores. Some people had more than one amputation, some on both sides of the body. Amputations mainly involve removal of the toe or part of the foot however, amputations involving the leg, below and above the knee, have also occurred. INVOKANA ® may increase your risk of lower-limb amputations. INVOKANA ® can cause serious side effects, including: If you are having any difficulty accessing cost support through the Janssen CarePath Savings Program, please contact us at 877-INVOKANA (87). The cost support is meant solely for patients-not health plans and/or their partners. This benefit is intended to help eligible patients afford their out-of-pocket obligations as set by their health plans. We provide cost support directly to patients through the Janssen CarePath Savings Program. Terms expire at the end of each calendar year and may change. Not valid for patients using Medicare, Medicaid, or other government-funded programs to pay for their medications. There is a $3,000 maximum program benefit per calendar year.
There is no limit to this benefit for your first month of treatment, and then $200 limit for each month thereafter. Eligible commercial patients pay $0 per month for INVOKANA ®, subject to program benefit limits. Depending on the health insurance plan, savings may apply toward co-pay, co-insurance, or deductible. Janssen CarePath Savings Program for INVOKANA ®Įligible patients using commercial or private insurance can save on out-of-pocket costs for INVOKANA ®.